Universidad de la Frontera   Report issue

Academic/Hospital Phase 4
Founded: Temuco Chile (1981)

Organization Overview

First Clinical Trial
2017
NCT03877120
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Universidad de la Frontera

Active Ingredients

Drugs in Phase 4 Trials (2)

dexmedetomidine (precedex) (1 trial)

diazepam (valium) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alcohol Withdrawal Delirium (Phase 4)

Delirium (Phase 4)

Substance Withdrawal Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2